Back to search

Article

Identification of bazedoxifene for the treatment of LGMD R2 by high throughput screening

2024-03-04

Abstract excerpt

LGMD R2 is a rare genetic disorder characterized by progressive proximal muscle weakness and wasting caused by a recessive loss of function of dysferlin, a transmembrane protein controlling plasma membrane repair in skeletal muscles. We report here the development of an in vitro high-throughput assay using immortalized myoblasts and monitored reallocation of an aggregated mutant form of dysferlin ( DYSF L1341P )...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ba39649a-e391-588f-9a47-475358ebaabc
DOI
10.1101/2024.02.28.582550
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Identification of bazedoxifene for the treatment of LGMD R2 by high throughput screeningDOI 10.1101/2024.02.28.582550
Select a neighboring publication to make it the new centre.